highperformr logo

Brainomix's Overview

Total employees72
HeadquartersOxford
Founded2010

Brainomix is an AI-powered medical technology company dedicated to improving outcomes for patients with stroke, lung conditions (including Interstitial Lung Disease - ILD), and cancer. They develop and deploy award-winning, AI-driven software solutions that automate and standardize the interpretation of medical images, enabling clinicians to make faster, more informed treatment decisions. Their flagship product, e-Stroke, is a comprehensive AI platform for stroke imaging, widely adopted in hospitals globally. Brainomix aims to transform diagnostic and treatment pathways through innovative technology, making precision medicine a reality for more patients.

Where is Brainomix's Headquarters?

HQ Function

The Oxford headquarters serves as the central hub for Brainomix's global operations, including core research and development, product innovation, corporate strategy, finance, and executive leadership.

Notable Features:

Situated in a modern business park, the headquarters provides a contemporary and collaborative workspace designed to foster innovation. It likely features open-plan office spaces, meeting rooms equipped for global communication, and R&D facilities.

Work Culture:

Brainomix fosters a dynamic, mission-driven, and innovative work culture. Employees are passionate about leveraging AI to make a tangible impact on patient lives. The culture encourages collaboration, scientific excellence, continuous learning, and agility in a fast-paced medtech environment.

HQ Significance:

Its location in Oxford provides access to a rich ecosystem of academic institutions, research hospitals, a skilled talent pool, and a vibrant life sciences community, crucial for Brainomix's growth and innovation in AI medical imaging.

Values Reflected in HQ: The headquarters reflects Brainomix's core values of innovation, scientific rigor, collaboration, and a commitment to improving patient outcomes through advanced technology, providing an environment conducive to cutting-edge research and development.

Location:

Brainomix has established a significant global presence, with its AI-powered medical imaging solutions adopted in hospitals across numerous countries. The company supports healthcare professionals worldwide through direct operations in key markets like the UK, Germany, the USA, and India, as well as through a network of distribution partners. This global reach enables Brainomix to deploy its technology, support clinical trials, and foster collaborations to improve stroke, ILD, and cancer care internationally.

Street Address:

The Kirkhouse, 1 Rutley Way, Oxford Business Park South

City:

Oxford

State/Province:

Oxfordshire

Country:

United Kingdom

Brainomix's Global Presence

Hamburg, Germany

Address: Brainomix GmbH, Willy-Brandt-Straße 57, 20457 Hamburg, Germany

To strengthen Brainomix's presence in key European markets, providing localized support, fostering clinical partnerships, and driving adoption of its e-Stroke and e-ILD platforms in Germany.

Chicago, Illinois, USA

Address: Brainomix Inc., 125 S. Wacker Drive, Suite 300, Chicago, IL 60606, USA

To expand Brainomix's footprint in the significant United States healthcare market, facilitating clinical adoption, supporting research collaborations, and engaging with key stakeholders.

New Delhi, India

Address: Brainomix India Pvt Ltd, Level 2, Elegance, Mathura Road, Jasola, New Delhi 110025, India

To address the growing demand for advanced healthcare technology in India, providing localized expertise and adapting Brainomix's solutions to meet regional clinical needs and improve patient care.

Buying Intent Signals for Brainomix

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Brainomix

As of April 2025, Brainomix' leadership includes:

Dr. Michalis Papadakis - Co-Founder & Chief Executive Officer
Eric Greveson - Chief Technology Officer
Jeff Wyrtzen - Chief Commercial Officer
Riaz Rahman - Chief Financial Officer
Dr. George Harston - Chief Medical & Innovation Officer
Andrew Newey - VP Quality Assurance and Regulatory Affairs

Investors of Brainomix

Brainomix has been backed by several prominent investors over the years, including:

Parkwalk Advisors
Tencent
Oxford Science Enterprises
Chimera Abu Dhabi
Boehringer Ingelheim Venture Fund
Oxford University Innovation Fund

Executive New Hires/Exits in the Last 12 Months

Hire0
Exits0

Brainomix has maintained a stable C-suite over the past 12 months, with the existing executive team focused on driving growth and innovation following its Series C funding. No major C-level hires or departures have been publicly announced between mid-2023 and mid-2024.

Technology (Tech Stack) used by Brainomix

Discover the tools Brainomix uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Brainomix Email Formats and Examples

Brainomix primarily uses the firstname.lastname@brainomix.com email format for its employees. This is a common structure in professional and technology-oriented companies.

firstname.lastname@brainomix.com

Format

jane.doe@brainomix.com

Example

90%

Success rate

News and media

Business WireFebruary 20, 2024

Brainomix e-Stroke AI Software Improves Patient Outcomes and Reduces Treatment Times, According to New Multi-Centre UK Study

A new multi-center UK study published in the Journal of NeuroInterventional Surgery (JNIS) demonstrated that the implementation of Brainomix's e-Stroke AI software significantly improved patient outcomes and reduced treatment times for stroke patients. The study highlighted improved efficiency in the stroke care pathway....more

PR Newswire / Brainomix WebsiteJune 21, 2023

Brainomix Raises £16M Series C Funding to Expand AI-Powered Precision Medicine Platform Globally

Brainomix announced it has successfully closed a £16 million ($21 million) Series C funding round. The financing was co-led by existing investors Parkwalk Advisors and new investor Tencent, with participation from Oxford Science Enterprises and Chimera Abu Dhabi. The funds will be used to expand its commercial footprint, develop new AI solutions for lung fibrosis and cancer, and grow its team....more

Brainomix News / European Stroke JournalOctober 18, 2023

Results from the OXPLORE Study Published in the European Stroke Journal Show the Impact of e-Stroke in Improving Stroke Care in a Real-World Setting

The OXPLORE study, evaluating Brainomix's e-Stroke platform in a real-world setting across multiple UK hospitals, demonstrated significant improvements in stroke care pathways. Key findings included faster treatment decisions and increased rates of reperfusion therapy, underscoring the platform's clinical utility....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Brainomix, are just a search away.